Subscribe
Menu
Login
Login
Subscribe
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
March 2024
View This Issue
Archives
Features
Quarterly Magazine
Current Issue
Spring 2024
View This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
TS University
Scientific Services
Brush Up Summaries
Technique Talks
Journal Club
TS SciComm
Multimedia
Crossword Puzzles
eBooks
Infographics
Podcasts
Research Products Blog
Research Articles
Science Snapshot
Slideshows
Videos
Words for Nerds
Webinars
ADVERTISEMENT
404
Not Found
Is this what you were looking for?
tag biobusiness business cell molecular biology industry
Serendipity, Happenstance, and Luck: The Making of a Molecular Tool
Shelby Bradford, PhD
| Dec 4, 2023
| 10+ min read
The common fluorescent marker GFP traveled a long road to take its popular place in molecular biology today.
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady
| May 1, 2019
| 8 min read
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
The Pet Health Industry Takes on Canine Cancer
Diana Kwon
| Oct 17, 2022
| 9 min read
Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.
Quest for Research Freedom Fuels African Biotech Boom
Linda Nordling
| Jul 1, 2021
| 6 min read
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
Variation in Cannabis Testing Challenges a Young Industry
Katarina Zimmer
| Mar 1, 2020
| 10 min read
The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.
Keeping Up with IP
Kate Yandell
| Sep 1, 2014
| 8 min read
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
Betting on Biotech
Scott Veggeberg
| Apr 5, 1993
| 10 min read
Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.
Can “Gene Writing” Deliver What Gene Editing Can’t?
Dan Robitzski
| Dec 12, 2022
| 10+ min read
A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?
Banking on iPSCs
Kerry Grens
| Jun 29, 2014
| 6 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Banking on iPSCs
Kerry Grens
| Sep 1, 2014
| 5 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Run a Search
ADVERTISEMENT